4//SEC Filing
Galvin Roy 4
Accession 0001127602-22-024920
CIK 0000313143other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:54 PM ET
Size
6.9 KB
Accession
0001127602-22-024920
Insider Transaction Report
Form 4
Galvin Roy
EVP, Chief Commercial Officer
Transactions
- Award
Non-qualified Stock Option (Right to Buy)
2022-11-01+5,263→ 5,263 totalExercise: $83.96Exp: 2029-11-01→ Common Stock (5,263 underlying) - Award
Common Stock
2022-11-01+2,382→ 2,382 total
Footnotes (3)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001950021
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:54 PM ET
- Size
- 6.9 KB